Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mehta

Showing results (1051-1060 of 1,180) with videos related to

Pageof 118
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2022
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trialPhilippe Gabriel Steg, Deepak L Bhatt, Stefan K James, et al.
CJC Open|September 2, 2025
Efficacy and Safety of Transcatheter Mitral Valve Edge-to-Edge Repair with a MitraClip Device in Real-World Canadian PracticeShamir R Mehta, Anita Asgar, Robert Boone, et al.
Circulation. Cardiovascular Interventions|September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE TrialZardasht Oqab, Vijay Kunadian, David A Wood, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Circulation|March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot TrialShamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.
Circulation. Cardiovascular Interventions|July 29, 2021
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE TrialPayam Dehghani, Warren J Cantor, Jia Wang, et al.
Circulation|October 29, 2008
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trialsShamir R Mehta, William E Boden, John W Eikelboom, et al.
European Heart Journal. Acute Cardiovascular Care|October 21, 2020
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategyBatric Popovic, Emmanuel Sorbets, Jeremie Abtan, et al.
Journal of the American Heart Association|April 20, 2017
Smokers and Postcessation Weight Gain After Acute Coronary SyndromePayam Dehghani, Bettina Habib, Sarah B Windle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
Pageof 118

Showing results (1051-1060 of 1,180) with videos related to

Sort By:
Pageof 118
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2022
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trialPhilippe Gabriel Steg, Deepak L Bhatt, Stefan K James, et al.
CJC Open|September 2, 2025
Efficacy and Safety of Transcatheter Mitral Valve Edge-to-Edge Repair with a MitraClip Device in Real-World Canadian PracticeShamir R Mehta, Anita Asgar, Robert Boone, et al.
Circulation. Cardiovascular Interventions|September 19, 2023
Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE TrialZardasht Oqab, Vijay Kunadian, David A Wood, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Circulation|March 23, 2005
Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot TrialShamir R Mehta, Philippe Gabriel Steg, Christopher B Granger, et al.
Circulation. Cardiovascular Interventions|July 29, 2021
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment-Elevation Myocardial Infarction: Insights From the COMPLETE TrialPayam Dehghani, Warren J Cantor, Jia Wang, et al.
Circulation|October 29, 2008
Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trialsShamir R Mehta, William E Boden, John W Eikelboom, et al.
European Heart Journal. Acute Cardiovascular Care|October 21, 2020
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategyBatric Popovic, Emmanuel Sorbets, Jeremie Abtan, et al.
Journal of the American Heart Association|April 20, 2017
Smokers and Postcessation Weight Gain After Acute Coronary SyndromePayam Dehghani, Bettina Habib, Sarah B Windle, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
Pageof 118